Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: Observations from the SAVOR-TIMI 53 trial

SAVOR-TIMI 53 Steering Committee and Investigators

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: Observations from the SAVOR-TIMI 53 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences